Reactome: A Curated Pathway Database
THIS SITE IS USED FOR CURATION AND TESTING
IT IS NOT STABLE, IS LINKED TO AN INCOMPLETE DATA SET, AND IS NOT MONITORED FOR PERFORMANCE. WE STRONGLY RECOMMEND THE USE OF OUR PUBLIC SITE

Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Name Email address

Details on Person Altun, Mikael

Class:IdPerson:5362651
_displayNameAltun, Mikael
_timestamp2014-04-16 20:09:15
created[InstanceEdit:5362685] D'Eustachio, Peter, 2014-04-16
firstnameMikael
initialM
surnameAltun
(author)[LiteratureReference:5362632] MTH1 inhibition eradicates cancer by preventing sanitation of the dNTP pool
[LiteratureReference:5689879] Structural basis and specificity of human otubain 1-mediated deubiquitination
[LiteratureReference:5690831] Post-translational modification of the deubiquitinating enzyme otubain 1 modulates active RhoA levels and susceptibility to Yersinia invasion
[LiteratureReference:6781790] Ubiquitin-specific protease 19 (USP19) regulates hypoxia-inducible factor 1α (HIF-1α) during hypoxia
[LiteratureReference:9858511] Targeting CDK2 overcomes melanoma resistance against BRAF and Hsp90 inhibitors
[Change default viewing format]
No pathways have been reviewed or authored by Altun, Mikael (5362651)